Ads
related to: sanofi pharmaceuticals- About Us
Discover the Unique Approach
That Makes Genmab Different.
- Pipeline
Review our Pipeline and
See How We're Changing Treatment.
- Sign Up
Sign Up for Updates, News
and Much More.
- Antibody Science
Explore Our Unique Platforms
For Creating Antibody Treatments.
- About Us
Search results
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
Zacks via Yahoo Finance· 18 hours agoSanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with...
Sanofi to Spend $1.08 Billion to Boost Drug Production in France
The Wall Street Journal· 1 day agoSanofi said the bulk of the investment will double capacity of monoclonal antibody production, which...
Sanofi strikes $1bn deal with Fulcrum for muscular dystrophy drug
Pharmaceutical Technology via Yahoo Finance· 18 hours ago"Sanofi strikes $1bn deal with Fulcrum for muscular dystrophy drug" was originally created and...
Regeneron, Sanofi Get Speedy FDA Review of Dupixent in Younger CRSwNP Group
Morningstar· 22 hours agoRegeneron Pharmaceuticals and Sanofi have won Food and Drug Administration priority review of their application seeking expanded approval of their blockbuster ...
Sartorius Collaborates With Sanofi to Commercialize End-to-End Platform for Downstream Process...
NewMediaWire via Yahoo Finance· 4 hours agoSartorius selected as preferred partner for development and commercialization of integrated and...
Sanofi pays $80M to add Roche-rivaling Fulcrum drug to phase 3 rare disease pipeline
FierceBiotech· 21 hours agoSanofi is betting $80 million upfront on a GSK castoff ahead of a phase 3 readout. Fulcrum Therapeutics took the other side of the deal, handing Sanofi ...
Sanofi reaches agreement with Novavax regarding COVID-19 vaccine
WFMZ Eastern Pennsylvania and Western New Jersey· 4 days agoThe agreement involves co-commercializing the COVID-19 vaccine, developing novel COVID-19-Influenza...
French, US drug firms team up for Covid-flu shot
AFP via Yahoo Finance· 4 days agoFrench pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines...
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 4 days agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...
Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
Pharmaceutical Technology via Yahoo Finance· 18 hours agoCytokines such as these play key roles in inflammation. Regeneron and Sanofi, who began working...
Ad
related to: sanofi pharmaceuticals